Your session is about to expire
← Back to Search
Liothyronine (LT3) for Heart Failure (DOT3HF-HFrEF Trial)
DOT3HF-HFrEF Trial Summary
This trial is testing whether thyroid hormone therapy can help people with heart failure and low T3 levels.
- Heart Failure with Reduced Ejection Fraction
- Hypothyroidism
DOT3HF-HFrEF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowDOT3HF-HFrEF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.DOT3HF-HFrEF Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of liver disease called cirrhosis.You are using a left ventricular assist device (LVAD).You were hospitalized for heart failure within the last month.You have had a heart-related procedure or surgery in the past 2-6 months.You have an implanted device called an implantable cardioverter-defibrillator (ICD).You are unable to complete a specific exercise test called VO2max.You are taking medications or have gastrointestinal conditions that can interfere with the absorption or metabolism of thyroid hormone.You have a serious problem with your heart valves that has not been fixed yet.
- Group 1: Liothyronine (LT3)
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What aims is this research endeavor striving to fulfill?
"This 14-day clinical trial has one primary aim: achieving T3 Level. Secondary objectives include measuring NT-proBNP, Quality of Life through the KCCQ scale, and VO2 Max peak rate of oxygen consumption during exercise."
How many participants is this research endeavor accommodating?
"Affirmative. According to information published on clinicaltrials.gov, this medical study is still seeking patients to enroll in their trial. The initial posting date was February 11th 2020 and the listing has been updated most recently on August 2nd 2022; the investigators are looking for 28 individuals across a single site."
Are there any open enrollments for this medical experiment currently?
"This medical study, which was first shared on 2nd November 2020 is presently enrolling participants. Clinicaltrials.gov's records confirm that the trial has been updated as recently as 8th August 2022."
Share this study with friends
Copy Link
Messenger